Skip to main content
Log in

Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer

Which way to go?

  • short review
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Summary

In locally advanced rectal cancer, neoadjuvant chemoradiotherapy provides a significant benefit to local cancer control in addition to total mesorectal excision. However, in 10–40% of all patients, a complete clinical remission can be detected after completion of chemoradiotherapy. Recent studies have shown that those patients omitting radical surgery after successful neoadjuvant pretreatment can be safely managed within a close follow-up network without compromising short-term overall and disease-free survival. However, available data suggest that 20–30% of all patients assigned to a watch and wait regimen will eventually have to be transferred to surgical management due to local recurrence. Careful patient selection is key for a successful watch and wait approach and the choice of non-operative management should not be made after completion of staging but rather after neoadjuvant chemoradiotherapy. Selected patients need to be thoroughly informed that there is still no standardized follow-up protocol and no predefined follow-up period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017; https://doi.org/10.1093/annonc/mdx224.

    Article  PubMed  Google Scholar 

  2. Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, et al. Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol. 2012;23:2479–516. https://doi.org/10.1093/annonc/mds236.

    Article  CAS  PubMed  Google Scholar 

  3. D’Souza N, de Neree tot Babberich MPM, d’Hoore A, Tiret E, Xynos E, Beets-Tan RGH, et al. Definition of the Rectum. Ann Surg. 2019;270:955–9. https://doi.org/10.1097/SLA.0000000000003251.

    Article  PubMed  Google Scholar 

  4. Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003;227:371–7. https://doi.org/10.1148/radiol.2272011747.

    Article  PubMed  Google Scholar 

  5. Siddiqui MRS, Simillis C, Bhoday J, Battersby NJ, Mok J, Rasheed S, et al. A meta-analysis assessing the survival implications of subclassifying T3 rectal tumours. Eur J Cancer. 2018;104:47–61. https://doi.org/10.1016/j.ejca .2018.07.131.

    Article  CAS  Google Scholar 

  6. Bernstein TE, Endreseth BH, Romundstad P, Wibe A. Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg. 2009;96:1348–57. https://doi.org/10.1002/bjs.6739.

    Article  CAS  PubMed  Google Scholar 

  7. Dhadda AS, Bessell EM, Scholefield J, Dickinson P, Zaitoun AM. Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Clin Oncol. 2014;26:197–202. https://doi.org/10.1016/j.clon.2014.01.001.

    Article  CAS  Google Scholar 

  8. Glynne-Jones R, Mawdsley S, Novell JR. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language. Color Dis. 2006;8:800–7. https://doi.org/10.1111/j.1463-1318.2006.01139.x.

    Article  CAS  Google Scholar 

  9. MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology. 2007;243:132–9. https://doi.org/10.1148/radiol.2431051825.

    Article  Google Scholar 

  10. Taylor FGM, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5‑year follow-up results of the MERCURY study. J Clin Oncol. 2013;32:34–43. https://doi.org/10.1200/JCO.2012.45.3258.

    Article  PubMed  Google Scholar 

  11. Glimelius B, Tiret E, Cervantes A, Arnold D. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; https://doi.org/10.1093/annonc/mdt240.

    Article  PubMed  Google Scholar 

  12. Stijns RCH, De Graaf EJR, Punt CJA, Nagtegaal ID, Nuyttens JJME, Van Meerten E, et al. Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study. JAMA Surg. 2019;154:47–54. https://doi.org/10.1001/jamasurg.2018.3752.

    Article  PubMed  Google Scholar 

  13. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; https://doi.org/10.1056/NEJMoa040694.

    Article  PubMed  Google Scholar 

  14. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006; https://doi.org/10.1056/NEJMoa060829.

    Article  PubMed  Google Scholar 

  15. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006; https://doi.org/10.1002/bjs.5506.

    Article  PubMed  Google Scholar 

  16. Chen K, Xie G, Zhang Q, Shen Y, Zhou T. Comparison of short-course with long-course preoperative neoadjuvant therapy for rectal cancer: a meta-analysis. J Cancer Res Ther. 2018;14:S224–S31. https://doi.org/10.4103/0973-1482.202231.

    Article  CAS  PubMed  Google Scholar 

  17. Glimelius B. On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery. Ups J Med Sci. 2017; https://doi.org/10.1080/03009734.2016.1274806.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Bernier L, Balyasnikova S, Tait D, Brown G. Watch-and-wait as a therapeutic strategy in rectal cancer. Curr Colorectal Cancer Rep. 2018;14:37–55. https://doi.org/10.1007/s11888-018-0398-5.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Silva E Sousa AH, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy. Ann Surg. 2004;240:711–8. https://doi.org/10.1097/01.sla.0000141194.27992.32.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Rombouts AJM, Al-Najami I, Abbott NL, Appelt A, Baatrup G, Bach S, et al. Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study. Bmj Open. 2017;7:e19474. https://doi.org/10.1136/bmjopen-2017-019474.

    Article  PubMed  PubMed Central  Google Scholar 

  21. van der Valk M, Hilling D, Bastiaannet E, Al E. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391:2537–45.

    Article  Google Scholar 

  22. Habr-Gama A, Perez RO. Non-operative management of rectal cancer after neoadjuvant chemoradiation. Br J Surg. 2009; https://doi.org/10.1002/bjs.6470.

    Article  PubMed  Google Scholar 

  23. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47. https://doi.org/10.1016/j.ejca .2008.10.026.

    Article  CAS  Google Scholar 

  24. Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): A propensity-score matched cohort analysis. Lancet Oncol. 2016; https://doi.org/10.1016/S1470-2045(15)00467-2.

    Article  PubMed  Google Scholar 

  25. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data. Lancet Oncol. 2010; https://doi.org/10.1016/S1470-2045(10)70172-8.

    Article  PubMed  Google Scholar 

  26. Glynne-Jones R, Hughes R. Critical appraisal of the “wait and see” approach in rectal cancer for clinical complete responders after chemoradiation. Br J Surg. 2012;99:897–909. https://doi.org/10.1002/bjs.8732.

    Article  CAS  PubMed  Google Scholar 

  27. Hupkens BJP, Martens MH, Stoot JH, Berbee M, Melenhorst J, Beets-Tan RG, et al. Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection—A matched-controlled study. Dis Colon Rectum. 2017; https://doi.org/10.1097/DCR.0000000000000862.

    Article  PubMed  Google Scholar 

  28. Feeney G, Sehgal R, Sheehan M, Hogan A, Regan M, Joyce M, et al. Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol. 2019;25:4850–69. https://doi.org/10.3748/wjg.v25.i33.4850.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kim MJ, Cho JS, Kim EM, Ko WA, Oh JH. Optimal time interval for surgery after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: Analysis of health insurance review and assessment service data. Ann Coloproctol. 2018;34:241–7. https://doi.org/10.3393/ac.2018.01.01.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Creavin B, Ryan E, Martin ST, Hanly A, O’connell PR, Sheahan K, Winter DC. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. 2017. https://doi.org/10.1038/bjc.2016.417.

    Book  Google Scholar 

  31. Maas M, Beets-Tan RGH, Lambregts DMJ, Lammering G, Nelemans PJ, Engelen SME, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29:4633–40. https://doi.org/10.1200/JCO.2011.37.7176.

    Article  PubMed  Google Scholar 

  32. Li J, Liu H, Yin J, Liu S, Hu J, Du F, et al. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: A cohort study. Oncotarget. 2015;6:42354–61. https://doi.org/10.18632/oncotarget.6093.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Smith JD, Ruby JA, Goodman KA, Saltz LB, Guillem JG, Weiser MR, et al. Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg. 2012;256:965–72. https://doi.org/10.1097/SLA.0b013e3182759f1c.

    Article  PubMed  Google Scholar 

  34. Smith JJ, Strombom P, Chow OS, Roxburgh CS, Lynn P, Eaton A, et al. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients with a Complete Response after Neoadjuvant Therapy. JAMA Oncol. 2019; https://doi.org/10.1001/jamaoncol.2018.5896.

    Article  PubMed  PubMed Central  Google Scholar 

  35. do Canto LM, Cury SS, Barros-Filho MC, Kupper BEC, Scapulatempo-Neto BEC, de S. Begnami MDF, et al. Locally advanced rectal cancer transcriptomic-based secretome analysis reveals novel biomarkers useful to identify patients according to neoadjuvant chemoradiotherapy response. Sci Rep. 2019; https://doi.org/10.1038/s41598-019-45151-w.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Wang S‑J, Hathout L, Malhotra U, Maloney-Patel N, Kilic S, Poplin E, et al. Decision-making strategy for rectal cancer management using radiation therapy for elderly or comorbid patients. Int J Radiat Oncol Biol Phys. 2018; https://doi.org/10.1016/j.ijrobp.2017.12.261.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Kong JC, Guerra GR, Warrier SK, Ramsay RG, Heriot AG. Outcome and salvage surgery following “watch and wait” for rectal cancer after neoadjuvant therapy: a systematic review. Dis Colon Rectum. 2017;60:335–45. https://doi.org/10.1097/DCR.0000000000000754.

    Article  PubMed  Google Scholar 

  38. Dattani M, Heald RJ, Goussous G, Broadhurst J, São Julião GP, Habr-Gama A, et al. Oncological and survival outcomes in Watch and Wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer a systematic review and pooled analysis. Ann Surg. 2018;268:955–67. https://doi.org/10.1097/SLA.0000000000002761.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Georgios Peros MD.

Ethics declarations

Conflict of interest

F. Lunger and G. Peros declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lunger, F., Peros, G. Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer. memo 13, 324–328 (2020). https://doi.org/10.1007/s12254-020-00586-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-020-00586-0

Keywords

Navigation